Vivus, Inc.

Now Accepting Content
Takeda and Lundbeck Announce FDA Approval of Brintellix™ (vortioxetine) for Treatment of Adults with Major Depressive Disorder
Introducing the New Kid on the Block to Treat Depression: “Brintellix”.
Meet the Executive Eli Lilly and Company Leadership Team: Fionnuala M. Walsh
Meet the Executive Eli Lilly and Company Leadership Team: Jacques Tapiero